Statements (54)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
chemical compound
|
| gptkbp:application |
used in cancer research
therapeutic agent in oncology |
| gptkbp:avionics |
several analogs developed
|
| gptkbp:built |
requires further optimization
|
| gptkbp:campusFacilities |
gptkb:XYZ_University
|
| gptkbp:chemicalFormula |
thiazole derivatives
crystalline solid contains thiazole ring C12H15N3O2 |
| gptkbp:clinicalTrials |
undergoing phase I trials
|
| gptkbp:collaborations |
gptkb:ABC_Pharmaceuticals
international research collaboration involved in several projects |
| gptkbp:compatibleWith |
inhibitor
|
| gptkbp:composedOf |
via multi-step organic synthesis
|
| gptkbp:dissolved |
soluble in DMSO
|
| gptkbp:drugInterdiction |
oral bioavailability
|
| gptkbp:endOfLife |
4 hours
|
| gptkbp:enginePower |
7.4
|
| gptkbp:environmentalImpact |
low toxicity in vitro
|
| gptkbp:financial_aid |
stable under dry conditions
|
| gptkbp:funding |
funded_by_NIH
|
| gptkbp:future_plans |
exploration of combination therapies
|
| https://www.w3.org/2000/01/rdf-schema#label |
WPC-970
|
| gptkbp:iceClass |
150-155°C
|
| gptkbp:impact |
potential toxicity
|
| gptkbp:isATypeOf |
123456-78-9
|
| gptkbp:market |
not commercially available
|
| gptkbp:nutritionalValue |
metabolized by liver enzymes
|
| gptkbp:origin |
N-(4-(4-(dimethylamino)phenyl)thiazol-2-yl)benzamide
|
| gptkbp:patentCitation |
patented compound
protected by international patents |
| gptkbp:patentStatus |
pending
|
| gptkbp:publications |
multiple peer-reviewed articles
|
| gptkbp:regulatoryBody |
high affinity for target
|
| gptkbp:regulatoryCompliance |
not yet approved
|
| gptkbp:related_to |
similar_to_WPC-971
|
| gptkbp:releaseYear |
discovered in 2020
|
| gptkbp:research |
gaining interest
ongoing studies in animal models show promising results |
| gptkbp:research_areas |
oncology
|
| gptkbp:research_focus |
targeting cancer pathways
|
| gptkbp:safety |
handle with care
|
| gptkbp:safety_features |
under evaluation
|
| gptkbp:storage |
store_at_-20°C
|
| gptkbp:targets |
human cells
specific protein kinases |
| gptkbp:team |
2.5
|
| gptkbp:triggerType |
inhibits cell proliferation
|
| gptkbp:uses |
research in pharmacology
|
| gptkbp:waterManagement |
primarily renal
|
| gptkbp:weight |
233.27 g/mol
|